AIDS-Related Lymphoma

Seminars in Oncology Nursing

Volumn 22, Issue 2, 2006, Pages 80-89

  Levine, Alexandra M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; B CELL LYMPHOMA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INCIDENCE; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; UNITED STATES;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HUMANS; INCIDENCE; LYMPHOMA, AIDS-RELATED; PROGNOSIS; RECURRENCE; UNITED STATES;

EID: 33646542661     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2006.01.004     Document Type: Article

References (72)

1. Frizzera C., Rosai J., Dehner L.P., et al. Lymphoreticular disorders in primary immunodeficiency. New findings based on an updated histologic classification of 35 cases. Cancer 46 (1980) 692-699
2. Penn I. Tumors of the immunocompromised patient. Annu Rev Med 39 (1988) 63-73
3. Purtilo D.T. Opportunistic non-Hodgkin's lymphoma in X-linked recessive immunodeficiency and lymphoproliferative syndromes. Semin Oncol 4 (1977) 335-343
4. Zulman J., Jaffe R., and Talal N. Evidence that the malignant lymphoma of Sjogren's syndrome is a monoclonal D cell neoplasm. N Engl J Med 299 (1978) 1215-1220
5. Anderson L.G., and Talal N. The spectrum of benign to malignant lymphoproliferation in Sjogren's syndrome. Clin Exp Immunol 10 (1972) 199-201
6. Burke J.S., Butler J., and Fuller L.M. Malignant lymphomas of the thyroid. A clinical-pathologic study of 35 patients including ultrastructural observations. Cancer 39 (1977) 1587-1602
7. Levine A.M., Taylor C.R., Schneider D.R., et al. Immunoblastic sarcoma of T cell versus B cell origin: I. Clinical features. Blood 58 (1981) 52-61
8. Penn I. Cancers complicating organ transplantation. N Engl J Med 323 (1990) 1767-1769
9. Swinnen L.J., Costanzo-Nordin M.R., Fisher S.G., et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 323 (1990) 1723-1728
10. Centers for Disease Control. Diffuse, undifferentiated non-Hodgkin's lymphoma among homosexual males-United States. MMWR Morb Mortal Wkly Rep 31 (1982) 277-279
11. Centers for Disease Control. Update on acquired immune deficiency syndrome (AIDS)-United States. MMWR Morb Mortal Wkly Rep 31 (1982) 507-508
12. Centers for Disease Control. Revision of the case definition of acquired immunodeficiency syndrome for national reporting-United States. Ann Intern Med 103 (1985) 373-375
13. Beral V., Peterman T., Berkelman R., et al. AIDS-associated non-Hodgkin's lymphoma. Lancet 337 (1991) 805-809
14. Palella Jr. F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338 (1998) 853-860
15. Ledergerber B., Telenti A., and Effer M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy. Prospective cohort study. Br Med J 319 (1999) 23-24
16. Mocroft A., Katama C., Johnson A.M., et al. AIDS across Europe, 1994-1998. The EuroSIDA study. Lancet 356 (2000) 291-296
17. Levine A.M. Lymphoma complicating immunodeficiency disorders. Ann Oncol 4 suppl 2 (1994) S29-S35
18. DeVesa S.S., and Fears T. Non-Hodgkin's lymphoma time trends: U.S. and international data. Cancer Res 52 (1992) 5432-5440
19. Rabkin C.S., Biggar R.J., and Horm J.W. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer 47 (1991) 692-696
20. Biggar R.J., and Rabkin C.S. The epidemiology of acquired immunodeficiency syndrome-related lymphomas. Curr Opin Oncol 4 (1992) 883-893
21. Grulich A.E., Wan X., Law M.G., et al. B cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS 14 (2000) 144-140
22. Cote T.R., Biggar R.F., Rosenberg P.S., et al. Non-Hodgkin's lymphoma among people with AIDS. Incidence, presentation and public health burden. Int J Cancer 73 (1997) 645-650
23. Biggar R.J., Rosenberg P.S., and Cote T. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Int J Cancer 68 (1996) 754-758
24. Biggar R.J., Engels E.A., Frisch M., et al. Risk of T cell lymphomas in persons with AIDS. J AIDS 26 (2001) 371-376
25. Peters B.S., Beck E., Coleman D.G., et al. Changing disease patterns in patients with AIDS in a referral center in the United Kingdom. The changing face of AIDS. Br Med J 302 (1991) 203-207
26. Nelson R.A., Levine A.M., and Bernstein L. Reproductive factors and risk of intermediate or high grade B cell non-Hodgkin's lymphoma in women. J Clin Oncol 19 (2001) 1381-1387
27. Holly E.A., Lele C., and Bracci P. Non-Hodgkin's lymphoma in homosexual men in the San Francisco Bay area. Occupational, chemical and environmental exposures. J AIDS 15 (1997) 223-231
28. Dean M., Jacobson L.P., McFarlane G., et al. Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-Δ32 mutation. Cancer Res 59 (1999) 3561-3564
29. Rabkin C.S., Yang Q., Goedert J.J., et al. Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1 infected individuals. Blood 93 (1999) 1838-1842
30. Besson C., Goubar A., Gabarre J., et al. Changes in AIDS related lymphoma since the era of highly active antiretroviral therapy. Blood 98 (2001) 2339-2344
31. NCI Non-Hodgkin's Lymphoma Classification Project Writing Committee. Classification of Non-Hodgkin's lymphomas. Reproducibility of major classification systems. Cancer 55 (1985) 91-95
32. Levine A.M., Gill P.S., Meyer P.R., et al. Retrovirus and malignant lymphoma in homosexual men. JAMA 254 (1985) 1921-1925
33. Knowles D.M., Chamulak G.A., Subar M., et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University experience. Ann Intern Med 108 (1988) 744-753
34. Lowenthal D.A., Straus D.J., Campbell S.W., et al. AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 61 (1988) 2325-2337
35. Kaplan L.D., Abrams D.I., Feigal E., et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 261 (1989) 719-724
36. Ziegler J.L., Beckstead J.A., Volberding P.A., et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311 (1984) 565-570
37. Lukes R.J., Parker J.W., Taylor C.R., et al. Immunologic approach to non-Hodgkin's lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases. Semin Hematol 15 (1978) 322-351
38. Centers for Disease Control. Revision of the Centers for Disease Control and Prevention surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 36 suppl 1 (1987) lS-15S
39. Levine A.M. Acquired immunodeficiency syndrome-related lymphoma [Review]. Blood 80 (1992) 8-20
40. Levine A.M., Sadeghi S., Espina B., et al. characteristics of indolent non-Hodgkin's lymphoma in patients with type 1 Human Immunodeficiency virus infection. Cancer 94 (2002) 1500-1506
41. Horning S.J., and Rosenberg S.A. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 311 (1984) 1471-1475
42. Ciobanu N., Andreef M., Safai B., et al. Lymphoblastic neoplasia in a homosexual patient with Kaposi's sarcoma. Ann Intern Med 98 (1983) 151-155
43. Presant C.A., Gala K., Wiseman C., et al. Human immunodeficiency virus-associated T-cell lymphoblastic lymphoma in AIDS. Cancer 60 (1987) 1459-1461
44. Goldstein J., Becker N., DelRowe J., et al. Cutaneous T-cell lymphoma in a patient infected with HIV, type 1. Cancer 66 (1990) 1130-1132
45. Crane G.A., Variakojis D., Rosen S.T., et al. Cutaneous T-cell lymphoma in patients with human immunodeficiency virus infection. Arch Dermatol 127 (1991) 989-994
46. Sternlieb J., Mintzer D., Kwa D., et al. Peripheral T-cell lymphoma in a patient with the acquired immunodeficiency syndrome. Am J Med 85 (1988) 445
47. Shibata D., Brynes R., Rabinowitz A., et al. HTLV-I associated adult T cell leukemia lymphoma in a patient infected with HIV-1. Ann Intern Med 111 (1989) 871-875
48. Gill P.S., Harrington W., Kaplan M.H., et al. Treatment of adult T cell leukemia-lymphoma with a combination of interferon alpha and zidovudine. N Engl J Med 332 (1995) 1744-1748
49. Chadburn A., Cesarman E., Jagirdar J., et al. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the HIV. Cancer 72 (1993) 3078-3090
50. Seneviratne L., Tulpule A., Espina B.M., et al. Clinical, immunologic and pathologic correlates of bone marrow involvement in 291 patients with AIDS related lymphoma. Blood 98 (2001) 2358-2363
51. Levine A.M., Zuckerman E., Zuckerman T., et al. Lack of association between hepatitis C infection and development of AIDS related lymphoma. J AIDS Hum Retrovirol 20 (1999) 255-258
52. Zuckerman E., Zuckerman T., Douer D., et al. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer 83 (1998) 1224-1230
53. Straus D.J., Juang J., Testa M.A., et al. Prognostic factors in the treatment of HIV associated non-Hodgkin's lymphoma: Analysis of AIDS Clinical Trials Group protocol 142: Low dose versus standard dose m-BACOD plus GM-CSF. J Clin Oncol 16 (1998) 3601-3606
54. Lim S.T., Karim R., Nathwani B.N., et al. AIDS related Burkitt's lymphoma versus diffuse large cell lymphoma in the pre-HAART and HAART eras. Significant differences in survival with standard chemotherapy. J Clin Oncol 23 (2005) 4430-4438
55. Rossi G., Donisi A., Casari S., et al. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with HIV related systemic non-Hodgkin's lymphoma. Cancer 86 (1999) 2391-2397
56. Lim S.T., Karim R., Tulpule A., et al. Prognostic factors in HIV related diffuse large cell lymphoma. Before versus after highly active antiretroviral therapy. J Clin Oncol 23 (2005) 8477-8482
57. Levine A.M., Wernz J.C., Kaplan L., et al. Low dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial. JAMA 266 (1991) 84-88
58. Kaplan L.D., Straus D.J., Testa M.A., et al. Randomized trial of standard-dose versus low dose mBACOD chemotherapy for HIV-associated non-Hodgkin's lymphoma. N Engl J Med 336 (1997) 1641-1648
59. Ratner L., Lee J., Tang S., et al. Chemotherapy for HIV associated non-Hodgkin's lymphoma in combination with highly active anti-retroviral therapy. J Clin Oncol 19 (2001) 2171-2178
60. Gill P.S., Rarick M.U., Brynes R.L., et al. Azidothymidine and bone marrow failure in AIDS. Ann Intern Med 107 (1987) 502-505
61. Antinori A., Cingolani A., Alba L., et al. Better response to chemotherapy and prolonged survival in AIDS related lymphomas responding to highly active antiretroviral therapy. AIDS 15 (2001) 1483-1491
62. Vaccher E., Spina M., de Gennaro G., et al. concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with Human Immunodeficiency Virus-related non-Hodgkin's lymphoma. Cancer 91 (2001) 155-163
63. Hoffmann C., Wolf E., Fatkenheuer G., et al. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS related lymphoma. AIDS 17 (2003) 1521-1529
64. Little R.F., Pittaluga S., Grant N., et al. Highly effective treatment of acquired immunodeficiency syndrome related lymphoma with dose adjusted EPOCH. Impact of antiretroviral therapy suspension and tumor biology. Blood 101 (2003) 4653-4659
65. Coiffier B., Lepage E., Briere J., et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B cell lymphoma. N Engl J Med 346 (2002) 235-242
66. Kaplan L.D., and Scadden D.T. No benefit from rituximab in a randomized phase III trial of CHOP with or without rituximab for patients with HIV associated non-Hodgkin's lymphoma. AIDS malignancies consortium study 010 [abstract 2268]. Proc Am Soc Clin Oncol 22 (2003) 564
67. Meynard J.-L., Guiguet M., Fonquernie L., et al. Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV infected patients and their epidemiologic characteristics. HIV Med 4 (2003) 127-132
68. Borg C., Ray-Coquard I., Philip I., et al. CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer. Cancer 101 (2004) 2675-2680
69. Boue F., Gabarre J., Gisselbrecht C., et al. CHOP chemotherapy plus rituximab in HIV patients with high grade lymphoma-results of an ANRS trial [abstract 1824]. Blood 100 (2002) 470a
70. Errante D., Santarossa S., Antinori A., et al. Second line chemotherapy with CDE in patients with resistant HIV related non-Hodgkin's lymphoma [abstract]. Proc Am Soc Clin Oncol 17 (1998) 57a
71. Bi J., Espina B.M., Tulpule A., et al. High dose cytosine arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS related non-Hodgkin's lymphoma. J AIDS 28 (2001) 416-421
72. Krishnan A., Zaia J., and Forman S.J. Should HIV positive patients with lymphoma be offered stem cell transplants?. Bone Marrow Transplant 32 (2003) 741-748